2882 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Drilon
    Drilon
  4. Rudin
    Rudin
  5. Hellmann
    Hellmann
  6. Ladanyi
    Ladanyi
  7. Chaft
    Chaft
  8. Yu
    Yu
  9. Paik
    Paik
  10. Li
    Li

Groups

  1. Department of Medicine (2882)
  2. Solid Tumor Oncology Division (2882)
  3. Thoracic Oncology (2882)
  4. GSK Faculty (917)
  5. Human Oncology and Pathogenesis Program (536)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (503)
  7. Tow Center for Developmental Oncology (TCDO) (422)
  8. Surgery (407)
  9. Sloan Kettering Institute Postdocs (381)
  10. Epidemiology and Biostatistics (373)
  1. "Thoracic Oncology"
  2. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (1481)
  2. Journal Article (1218)
  3. Review (57)
  4. Editorial (37)
  5. Book Section (35)
  6. Conference Paper (20)
  7. Guidelines (18)
  8. Correspondence (5)
  9. Research Letter (5)
  10. Miscellaneous (4)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2882)
  2. Solid Tumor Oncology Division (2882)
  3. Thoracic Oncology (2882)
  4. GSK Faculty (917)
  5. Human Oncology and Pathogenesis Program (536)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (503)

More Groups

People
  1. Mark Kris (833)
  2. Gregory Riely (556)
  3. Alexander Drilon (517)
  4. Charles Rudin (412)
  5. Matthew Hellmann (398)
  6. Marc Ladanyi (376)

More People

Years
  1. 2023 (151)
  2. 2022 (336)
  3. 2021 (337)
  4. 2020 (257)
  5. 2019 (259)
  6. 2018 (251)

More Years

Publications
  1. Journal of Clinical Oncology (618)
  2. Journal of Thoracic Oncology (429)
  3. Annals of Oncology (230)
  4. Clinical Cancer Research (143)
  5. Cancer Research (125)
  6. International Journal of Radiation Oncology, Biology, Physics (74)

More Publications

Publishers
  1. American Society of Clinical Oncology (675)
  2. Elsevier Inc. (615)
  3. American Association for Cancer Research (349)
  4. Oxford University Press (283)
  5. Nature Publishing Group (123)
  6. Elsevier Science, Inc. (68)

More Publishers

Results (2882)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for patients with pleural metastases from thymic malignancies
    Meeting Abstract

    Rimner, A.; Huang, J.; Pagano, A.; Ginsberg, M. S.; Chang, J. C.; Riely, G. J.; Simone, C. B.; Gomez, D. R.; Shepherd, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R)
    Meeting Abstract

    Forde, P. M.; Nowak, A. K.; Hughes, B. G. M.; Kok, P. S.; Brown, C.; Sun, Z.; Anagnostou, V.; O'Byrne, K.; Yip, S.; Cook, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non–small-cell lung cancer
    Meeting Abstract

    Johnson, M. L.; Henry, J. T.; Spira, A. I.; Battiste, J.; Alnahhas, I.; Ahluwalia, M. S.; Barve, M. A.; Edenfield, W. J.; Nam, D. H.; Eathiraj, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of benefit to radiation for oligoprogressive disease in EGFR -mutant metastatic non-small cell lung cancer patients treated with osimertinib
    Meeting Abstract

    Chen, M. F.; Ma, J.; Kris, M. G.; Gomez, D. R.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Patient characteristics, treatment patterns, and clinical outcomes among patients with de novo advanced or metastatic (stage IIIB–IV) non-small cell lung cancer in a real-world setting
    Meeting Abstract

    Yang, M.; MacEwan, J. P.; Sriteja Boppudi, S.; McClain, M.; O'Hara, R.; Paik, P. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets)
    Meeting Abstract

    Sui, J. S. Y.; Wilcox, J.; Tischfield, S.; Choudhury, N. J.; Riely, G. J.; Kris, M. G.; Boire, A. A.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic landscape of EGFR -mutant lung cancers (LCs) with squamous and adenosquamous differentiation
    Meeting Abstract

    Elkrief, A.; Falcon, C. J.; Richards, A. L.; Dymun, A.; Paik, P. K.; Aly, R. G.; Rekhtman, N.; Rudin, C. M.; Quintanal-Villalonga, A.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Detection of MET amplification (METamp) in patients with EGFR mutant (m) NSCLC after first-line (1L) osimertinib
    Meeting Abstract

    Yu, H. A.; Kerr, K.; Rolfo, C. D.; Fang, J.; Finocchiaro, G.; Wong, K. H.; Veillon, R.; Kato, T.; Yang, J. C. H.; Nadal, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of diverse targetable alterations in ERBB2 and ERBB3 in 93,465 non-small cell lung cancers (NSCLC)
    Meeting Abstract

    Liu, D.; Keller, R. B.; Heilmann, A. M.; Allen, J.; Oxnard, G. R.; Bazhenova, L.; Schrock, A. B.; Li, B. T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save